Idamycin Pfs en es it fr

Idamycin Pfs Brand names, Idamycin Pfs Analogs

Idamycin Pfs Brand Names Mixture

  • No information avaliable

Idamycin Pfs Chemical_Formula


Idamycin Pfs RX_link

Idamycin Pfs fda sheet

Idamycin_Pfs FDA

Idamycin Pfs msds (material safety sheet)

Idamycin Pfs Synthesis Reference

No information avaliable

Idamycin Pfs Molecular Weight

497.494 g/mol

Idamycin Pfs Melting Point

No information avaliable

Idamycin Pfs H2O Solubility

No information avaliable

Idamycin Pfs State


Idamycin Pfs LogP


Idamycin Pfs Dosage Forms

Powder for solution

Idamycin Pfs Indication

For the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.

Idamycin Pfs Pharmacology

Idarubicin is an antineoplastic in the anthracycline class. General properties of drugs in this class include: interaction with DNA in a variety of different ways including intercalation (squeezing between the base pairs), DNA strand breakage and inhibition with the enzyme topoisomerase II. Most of these compounds have been isolated from natural sources and antibiotics. However, they lack the specificity of the antimicrobial antibiotics and thus produce significant toxicity. The anthracyclines are among the most important antitumor drugs available. Doxorubicin is widely used for the treatment of several solid tumors while daunorubicin and idarubicin are used exclusively for the treatment of leukemia. Idarubicin may also inhibit polymerase activity, affect regulation of gene expression, and produce free radical damage to DNA. Idarubicin possesses an antitumor effect against a wide spectrum of tumors, either grafted or spontaneous. The anthracyclines are cell cycle-nonspecific.

Idamycin Pfs Absorption

No information avaliable

Idamycin Pfs side effects and Toxicity

No information avaliable

Idamycin Pfs Patient Information

No information avaliable

Idamycin Pfs Organisms Affected

Humans, other mammals and bacteria